Page 108 - 《中国药房》2022年17期
P. 108

局限性:(1)原始文献只是考虑了5-HTR1A基因 C-1019G                        fluoxetine and serotonin 1A receptor(C-1019G)polymor-
        一个基因位点对抗抑郁药物的影响,而抑郁症的发生和                                 phism in Taiwan Chinese major depressive disorder[J].
        发展与多个基因连锁和环境的交互作用有关,并且还会                                 Pharmacogenomics J,2006,6(1):27-33.
        受到生理、心理、社会多方面的影响,可能会造成结果有                           [10]  ILLI A,SETÄLÄ-SOIKKELI E,VIIKKI M,et al. 5-
                                                                 HTR1A,5-HTR2A,5-HTR6,TPH1 and TPH2 polymor-
        一定的偏倚;(2)本次研究仅纳入了公开发表的文献,可
                                                                 phisms and major depression[J]. Neuroreport,2009,20
        能会存在一定的偏倚;(3)在方法学上很难控制纳入文
                                                                (12):1125-1128.
        献的干扰因素,并且对原始文献中的年龄、性别、家族史
                                                            [11]  KATO M,FUKUDA T,WAKENO M,et al. Effect of
        等无法进行评估,仍需要大量的研究进行验证。
                                                                 5-HT1A gene polymorphisms on antidepressant response
            综上所述,亚洲人群、中国地区的抑郁症患者                                 in major depressive disorder[J]. Am J Med Genet B Neu-
        5-HTR1A 基因 C-1019G 多态性与抗抑郁药物疗效有相                         ropsychiatr Genet,2009,150B(1):115-123.
        关性(GG vs. CG+CC),这对临床合理和个体化用药提                      [12]  LEMONDE S,DU L S,BAKISH D,et al. Association of
        供了一定的理论基础。当然,由于各种局限性,希望将                                 the C(-1019)G 5-HT1A functional promoter polymor-
        来有更多的大样本量研究来证实这一结果。                                      phism with antidepressant response[J]. Int J Neuropsycho-
        参考文献                                                     pharmacol,2004,7(4):501-506.
        [ 1 ]  李凌江,马辛.中国抑郁障碍防治指南[M]. 2版.北京:中                [13]  LIN E,CHEN P S,CHANG H H,et al. Interaction of sero-
             华医学电子音像出版社,2015:7.                                  tonin-related genes affects short-term antidepressant re-
                                                                 sponse in major depressive disorder[J]. Prog Neuropsycho-
        [ 2 ]  World Health Organization. Depression and other common
                                                                 pharmacol Biol Psychiatry,2009,33(7):1167-1172.
             mental disorders:global health estimates. No. WHO/MSD/
                                                            [14]  NORO M,ANTONIJEVIC I,FORRAY C,et al. 5HT1A
             MER/2017.2[EB/OL].[2022-02-24]. https://apps.who.int/
                                                                 and 5HT2A receptor genes in treatment response pheno-
             iris/bitstream/handle/10665/254610/WHO-MSD-MER-
                                                                 types in major depressive disorder[J]. Int Clin Psychophar-
             2017.2-eng.pdf.
        [ 3 ]  CIPRIANI A,FURUKAWA T A,SALANTI G,et al. Com-     macol,2010,25(4):228-231.
                                                            [15]  PARSEY R V,OLVET D M,OQUENDO M A,et al.
             parative efficacy and acceptability of 21 antidepressant
                                                                 Higher 5-HT1A receptor binding potential during a major
             drugs for the acute treatment of adults with major depres-
                                                                 depressive episode predicts poor treatment response:pre-
             sive disorder:a systematic review and network meta-ana-
                                                                 liminary data from a naturalistic study[J]. Neuropsycho-
             lysis[J]. Lancet,2018,391(10128):1357-1366.
                                                                 pharmacology,2006,31(8):1745-1749.
        [ 4 ]  FABBRI C,HOSAK L,MÖSSNER R,et al. Consensus
                                                            [16]  RAMESH V,VENKATESAN V,RAMASAMY B. Role
             paper of the WFSBP task force on genetics:genetics,  of serotonin transporter and receptor gene polymorphisms
             epigenetics and gene expression markers of major depres-
                                                                 in treatment response to selective serotonin reuptake inhi-
             sive disorder and antidepressant response[J]. World J Biol
                                                                 bitors in major depressive disorder[J]. Hum Psychophar-
             Psychiatry,2017,18(1):5-28.
                                                                 macol Clin Exp,2022,37(4):e2830.
        [ 5 ]  翟天柱,沈宗霖,许秀峰. 5-羟色胺 1A 受体及其基因
                                                            [17]  SCUTT G,OVERALL A,SCOTT R,et al. Does the 5-HT
             rs6295 位点多态性与抑郁症的研究进展[J].医学综述,
                                                                 1A rs6295 polymorphism influence the safety and efficacy
             2018,24(4):631-635.                                 of citalopram therapy in the oldest old? [J]. Ther Adv
        [ 6 ]  ARIAS B,CATALÁN R,GASTÓ C,et al. Evidence for a
                                                                 Drug Saf,2018,9(7):355-366.
             combined genetic effect of the 5-HT(1A)receptor and se-
                                                            [18]  SERRETTI A,ARTIOLI P,LORENZI C,et al. The C
             rotonin transporter genes in the clinical outcome of major  (-1019)G polymorphism of the 5-HT1A gene promoter
             depressive patients treated with citalopram[J]. J Psycho-  and antidepressant response in mood disorders:prelimi-
             pharmacol,2005,19(2):166-172.                       nary findings[J]. Int J Neuropsychopharmacol,2004,7
        [ 7 ]  BASU A,CHADDA R K,SOOD M,et al. Association of   (4):453-460.
             serotonin transporter(SLC6A4)and receptor(5HTR1A,  [19]  SERRETTI A,FABBRI C,PELLEGRINI S,et al. No ef-
             5HTR2A) polymorphisms with response to treatment    fect of serotoninergic gene variants on response to inter-
             with escitalopram in patients with major depressive disor-  personal counseling and antidepressants in major depres-
             der:a preliminary study[J]. Indian J Med Res,2015,142  sion[J]. Psychiatry Investig,2013,10(2):180-189.
             (1):40-45.                                     [20]  YU Y W Y,TSAI S J,LIOU Y J,et al. Association study
        [ 8 ]  CHANG H S,LEE H Y,CHA J H,et al. Interaction of 5-  of two serotonin 1A receptor gene polymorphisms and
             HTT and HTR1A gene polymorphisms in treatment re-   fluoxetine treatment response in Chinese major depressive
             sponses to mirtazapine in patients with major depressive  disorders[J]. Eur Neuropsychopharmacol,2006,16(7):
             disorder[J]. J Clin Psychopharmacol,2014,34(4):446-454.  498-503.
        [ 9 ]  HONG C J,CHEN T J,YU Y W Y,et al. Response to                                  (下转第2156页)


        ·2146 ·  China Pharmacy 2022 Vol. 33 No. 17                                 中国药房    2022年第33卷第17期
   103   104   105   106   107   108   109   110   111   112   113